BOSTON– LightSpun, an AI-powered dental insurance administration platform formerly known as 32Health, has raised $13 million in Series A funding led by Brewer Lane, with participation from Virtue, Cambrian, and Industry Ventures. The round brings the company’s total funding to $18 million. Rohan Malhotra of Brewer Lane and Sean Doolan of Virtue will join LightSpun’s board.
LightSpun aims to modernize an industry where nearly 300 million Americans still face claims processing delays of 15 to 60 days and where 18 percent of every premium dollar is lost to administrative overhead. The company’s automation tools adjudicate more than 90 percent of claims, cut provider onboarding from as long as two months to under a week, and reduce administrative costs by half.
This year, LightSpun doubled its annual recurring revenue and expanded its client base among payers and dental service organizations. Its platform now processes more than 175,000 providers. The company also partnered with the American Dental Association to launch AI-driven credentialing that simplifies provider onboarding nationwide.
“Dental insurance runs on infrastructure that most businesses abandoned decades ago. That’s why it’s ripe for automation, and why AI can meaningfully reshape industry economics and the experience for providers and patients,” said Rohan Malhotra, lead investor and General Partner at Brewer Lane. “LightSpun stands out not just for its AI platform, but for real traction solving administrative headaches for payers, group practices, DSOs, and the millions who just want faster, transparent, better care.”
The new funding will be used to enhance LightSpun’s AI platform, expand its engineering and product teams, simplify customer onboarding, and grow partnerships.
“Outdated technology holds everyone back, from payers to dentists and patients. Every manual step means weeks of delays and wasted cost,” said LightSpun CEO and co-founder Shaju Puthussery. “Our vision is better patient outcomes at a lower cost, powered by an AI-native health administration platform. We’re grateful for our investors’ support as we tackle the most invisible—and expensive—problem in healthcare.” (Source: IANS)
